Global Endoscopic probe disinfection Market - Market Overview:   

The Global Endoscopic probe disinfection Market is expected to grow from USD 480 Million in 2024 to USD 820.5 Million by 2033, at a CAGR of 5.89% during the projection period 2025-2033, driven by the rising prevalence of chronic diseases, increasing endoscopic procedures, and stringent infection prevention and control guidelines worldwide. Hospitals and clinics are under rising pressure to adopt advanced disinfection methods to minimize hospital-acquired infections (HAIs).

Automated probe reprocessors, UV-C powered disinfection, AI-powered tracking systems and green chemical formulations are some of the fast developing technologies in the market. The increasing need of high-level disinfection, especially in reusable flexible endoscopes, is increasing their uptake. Additionally, the emphasis on patient safety, government regulations and infection control efforts are contributing to innovation. Alliances among medical practitioners, medical device manufacturers and government regulators are also facilitating the development of standardised, environmentally friendly, and affordable disinfection protocols.

Request Sample: - Global Endoscopic probe disinfection Market

Market Dynamics:

Drivers:

• Rising demand for infection prevention

The increasing number of surgical procedures and the risk of infections worldwide challenges health care facilities to implement more sophisticated disinfection systems. Strict hygiene standards are rapidly stipulated by regulatory bodies, and reprocessing of endoscopes becomes an important issue. Patient safety and decreased human error promote the rapid adoption of automated technologies. The increased attention to healthcare-associated infections (HAIs) has only resulted in the ever-increasing need in reliable and efficient probe disinfection systems worldwide.

Restraints:

• High equipment and maintenance costs

Complex automated endoscope reprocesses and disinfectants have very high capital requirements and therefore cannot be adopted in smaller medical facilities. The repeated maintenance, chemical expenses and skilled technicians represent additional monetary strain. Such expensive solutions are not easily implemented in the developing regions. This price-sensitivity acts to deter expansion, especially in low- and middle-income markets, which slows the rate of market growth.

Opportunities:  

• Technological advancements in disinfection systems

The emergence of robotic-aided cleaning, artificial intelligence-capable process verification, and green disinfectants is changing the market. These technologies are more efficient, have a shorter turnaround time and less chemical is used. To access unexploited markets, manufacturers are paying attention to user-friendly sustainable systems. Never-ending research and development and integration of intelligent technologies offer immense growth and expansion possibilities in established and developing markets.

Challenges:  

• Limited awareness in developing regions

Most clinicians in developing economies do not have sufficient information regarding the infection control procedures of endoscopes. Manual cleaning methods are still widely practiced, increasing risks of contamination. Limited training infrastructure, weak regulatory enforcement, and budgetary constraints worsen the gap. Raising awareness, improving education, and providing cost-effective solutions remain crucial to overcome these barriers and achieve global infection control standards.

Segmentation Analysis: 

The Global Endoscopic probe disinfection Market has been segmented based on Product Type, Technique/Process, End user, Distribution Channel, and regions.  

By Product Type  

The product type includes High-Level Disinfectants (HLD), Chemical Sterilants, Automated Endoscope Reprocessors (AERs), UV-C Disinfection Systems, and Others. In 2024, High-Level Disinfectants (HLD) segment topped the Endoscopic Probe Disinfection Market by holding the largest share of around 39.2%. The market is dominated by Automated Endoscope Reprocessors (AERs) because these devices are efficient at delivering consistent high-level disinfection and minimize manual handling errors. The advantage of AERs to hospitals and clinics is that they lead to improved patient safety and a reduction in the risk of infections as well as adherence to international healthcare standards. They are the most popular product segment because of their automation, proven disinfection cycle and multiple scopes.

By Technique/Process   

The technique/process includes Manual Cleaning & Disinfection, Automated Cleaning & Disinfection, UV-C/Light-Based Disinfection, and Combination Methods. In 2024, Automated Cleaning & Disinfection segment led the market with a share of approximately 41.7% The strongest process in the market is disinfection (HLD). It is standardized, repeatable, and validated to offer cleaning cycles with reduced chances of contamination compared to manual cleaning methods. Automated HLD is efficient, safer, and in line with the recommendations of infection prevention, hence suitable in facilities where endoscopic surgery is conducted in large numbers. It is dominant in this segment because of its accuracy and efficiency.

By End-Use  

The end-use category includes Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Diagnostic Centers, and Others. In 2024, the Hospitals segment dominated the Endoscopic Probe Disinfection Market by holding the largest share of about 45.8%. Hospitals are the most common end-use sector, and the highest demand of endoscopic probe disinfection. Hospitals with large volumes of patients in gastroenterology, pulmonology, and urology among other specialties, need effective infection control solutions. They spend on automated reprocessors and modern disinfectants to comply with high standards of regulation. Hospitals dominate the global market because of their budgets, infrastructure and their focus on infection prevention.

By End user 

The distribution channel includes Direct Sales, Distributors, and Online Platforms. In 2024, Direct Sales segment dominated the market with around 47.3% share. The segment with the greatest distribution channel market share is Direct Sales since health care facilities focus on the manufacturers to ensure quality, service, and compliance. Long-term contracts, employee training, and tailor-made solutions offered via direct sales are beneficial to hospitals and clinics. This channel is more reliable, accountable, and has close partnerships, which are more desirable compared to distributors and online in critical healthcare settings.

Global Endoscopic probe disinfection Market - By Regional Analysis:

The regions analyzed for the Endoscopic probe disinfection Market include North America, Europe, APAC, LATAM & MEA. The North America region dominated the Endoscopic probe disinfection market and held a 42.0 % share of the market revenue in 2024.   

North America controls the Endoscopic Probe Disinfection Market through stringent infection control laws enforced by agencies like the U.S. Food and Drug Administration (FDA), Centers Disease Control and Prevention (CDC) and Association of Professionals in Infection Control (APIC). The region also enjoys good healthcare infrastructure, high uptake of automated reprocessors and high expenditure on infection prevention. The increasing humanization of endoscopy operations and hospital-acquired infections (HAIs), along with the presence of large major industrial medical device manufacturers, guarantees the dominance of the market in North America.   

Asia-Pacific is the most rapidly developing market due to the growth of healthcare investments, the rise of gastrointestinal and urology disease prevalence, and the increase in the use of minimally invasive procedures in China, India, and Japan. Demand is increasing due to government efforts to enhance infection control measures, and the rapid growth in the number of hospitals and diagnostic centers. Asia-Pacific is the most promising market to further invest in probe disinfection technologies considering the increasing prevalence of endoscopy procedures over the past few years and the increasing awareness of patient safety and infection risk.

Global Endoscopic probe disinfection Market - Country Analysis:

• US 

The United States rules the Endoscopic Probe Disinfection Market in North America with almost 78.5% share in 2024. The U.S. is the leader because of its developed healthcare facilities, large volumes of gastrointestinal and urology endoscopies, and stringent FDA and CDC infection prevention standards. The country is well placed by the presence of major medical device makers, high uptake of Automated Endoscope Reprocessor (AERs), and high investment in infection control. Increased hospital-acquired infections (HAIs) and emphasis on patient safety are additional factors that increase market.

• China

China is the leader in the Asia-Pacific Endoscopic Probe Disinfection Market with a 2024 market share of approximately 44.5%. The need to expand the healthcare infrastructure quickly, combined with the increasing number of gastrointestinal cancers, is driving the demand of disinfection technologies. The implementation of automated and high levels of disinfection is being increased by government-supported healthcare reforms, and new higher standards of hospital accreditation. Also, growing counts of endoscopic surgeries, robust local production of medical devices, and rising awareness of infection prevention have made China the biggest endoscopic probe disinfection center in Asia-Pacific.

Key Industry Players Analysis:  

To increase their market position in the Global Endoscopic Probe Disinfection Market, top companies are focusing on tactics such as adopting new technologies, mergers & acquisitions, Component developments, collaborations, partnerships, joint ventures, etc. 

• Advanced Sterilization Products (ASP)

• Ecolab Inc.

• Getinge AB

• STERIS plc 

• Olympus Corporation

• Metrex Research, LLC (Envista Holdings)

• Cantel Medical (a Steris company)

• Johnson & Johnson (Ethicon division)

• Wassenburg Medical (Hoya Group)

• Shinva Medical Instrument Co., Ltd.

Latest Development:

• In March 2025, the FDA approved the CORIS system by Nanosonics, developed to clean the intricate inner channels of flexible endoscopes—common sources of hospital-acquired infections. The automated system effectively targets biofilm buildup in narrow channels, an area often missed by manual brushing. These residues, formed from patient cells, can develop resistance to high-level disinfection after repeated cleaning cycles.
• In January 2025, Amity Ltd. launched SCOPE-Flush, a hands-free automated flushing system that replaces manual syringe flushing. It delivers a precise combination of detergent, water, and air through endoscope channels, ensuring consistent cleaning. The innovation minimizes manual handling errors, enhances user safety, and strengthens compliance with stringent disinfection standards while being compatible with all flexible endoscopes.

Report Metrics

Scope of the Report

Global Endoscopic probe disinfection Market by Product Type:

• High-Level Disinfectants (HLD)

• Chemical Sterilants

• Automated Endoscope Reprocessors (AERs)

• UV-C Disinfection Systems

• Others 

Global Endoscopic probe disinfection Market by Technique/Process:

• Manual Cleaning & Disinfection

• Automated Cleaning & Disinfection

• UV-C / Light-Based Disinfection 

• Combination Methods 

Global Endoscopic probe disinfection Market by End user:

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Specialty Clinics

• Diagnostic Centers

• Others

Global Endoscopic probe disinfection Market by Distribution Channel:

• Direct Sales

• Distributors / Wholesalers

• Online Platforms

Global Endoscopic probe disinfection Market by Region:

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • France

  • U.K.

  • Russia

  • Italy

  • Spain

  • Netherlands

  • Rest of Europe

• Asia Pacific

  • China

  • Japan

  • India  

  • New Zealand

  • Australia

  • South Korea

  • Taiwan

  • Rest of Asia Pacific

• The Middle East & Africa

  • Saudi Arabia

  • UAE 

  • Egypt 

  • Kuwait

  • South Africa

  • Rest of the Middle East & Africa

• Latin America

  • Brazil

  • Argentina 

  • Rest of Latin America